Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.

about

Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.

Item

http://www.wikidata.org/entity/Q47172693

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Stathmin 1 expression predicts ...... ts with gallbladder carcinoma.

@en

Stathmin 1 expression predicts ...... ts with gallbladder carcinoma.

@nl

type

Item

label

Stathmin 1 expression predicts ...... ts with gallbladder carcinoma.

@en

Stathmin 1 expression predicts ...... ts with gallbladder carcinoma.

@nl

prefLabel

Stathmin 1 expression predicts ...... ts with gallbladder carcinoma.

@en

Stathmin 1 expression predicts ...... ts with gallbladder carcinoma.

@nl

P1476

Stathmin 1 expression predicts ...... ts with gallbladder carcinoma.

@en

P2093

Houbao Liu

http://www.w3.org/2001/XMLSchema#string

Jie Wang

http://www.w3.org/2001/XMLSchema#string

Jiejie Xu

http://www.w3.org/2001/XMLSchema#string

Qiang Fu

http://www.w3.org/2001/XMLSchema#string

Xiaobo Bo

http://www.w3.org/2001/XMLSchema#string

Yueqi Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.

Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study.

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1.

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.

Predictive value of STMN1 gene promoter polymorphism (-2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine.

Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.

Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer

P304

108548-108555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19625

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312550

http://www.w3.org/2001/XMLSchema#string

P932

5752463

http://www.w3.org/2001/XMLSchema#string